1. Home
  2. TH vs VIR Comparison

TH vs VIR Comparison

Compare TH & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Hospitality Corp.

TH

Target Hospitality Corp.

HOLD

Current Price

$16.60

Market Cap

1.8B

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$8.60

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TH
VIR
Founded
1978
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
TH
VIR
Price
$16.60
$8.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$16.50
$19.43
AVG Volume (30 Days)
1.3M
1.5M
Earning Date
05-18-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
$320,635,000.00
$68,556,000.00
Revenue This Year
$17.45
$270.22
Revenue Next Year
$38.19
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.97
$4.16
52 Week High
$18.93
$11.66

Technical Indicators

Market Signals
Indicator
TH
VIR
Relative Strength Index (RSI) 49.80 41.89
Support Level $6.50 $8.48
Resistance Level $18.83 $10.10
Average True Range (ATR) 0.56 0.43
MACD -0.31 -0.04
Stochastic Oscillator 23.47 20.96

Price Performance

Historical Comparison
TH
VIR

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services, including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. The company has three reportable segments: HFS - South, which provides specialty rental and hospitality services to the natural resources and development industry; WHS, which provides construction and hospitality solutions for critical mineral and data center projects; and Government, which provides specialty rental and hospitality services under government contracts.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: